Literature DB >> 27492659

Severe prosthesis-patient mismatch after aortic valve replacement for aortic stenosis: Analysis of risk factors for early and long-term mortality.

Vito Mannacio1, Luigi Mannacio2, Emilo Mango3, Anita Antignano4, Michele Mottola2, Sergio Caparrotti3, Francesco Musumeci5, Carlo Vosa2.   

Abstract

BACKGROUND: Severe prosthesis-patient mismatch (PPM) is considered to further decrease survival compared to moderate PPM. This study aimed to assess the impact of severe PPM on survival after aortic valve replacement (AVR).
METHODS: We retrospectively studied 2404 consecutive patients with PPM who underwent first-time AVR for pure stenosis between January 2003 and December 2014. Mismatch was moderate for indexed effective valve orifice >0.65 to <0.85cm2/m2 and severe for indexed effective valve orifice ≤0.65cm2/m2. Moderate mismatch occurred in 2165 patients (89%), and severe in 239 (11%) patients. Logistic multiple regression with bootstrapping and propensity score analyses were performed using 29 clinical and demographic data to assess the risk-adjusted impact of severe mismatch on mortality. The Cox proportional hazards model was constructed to process the long-term outcome.
RESULTS: Early mortality was 2.3% (51/2165) in moderate mismatch group and 3.7% (9/239) in severe mismatch group (p=0.2). Mortality at 5 and 10 years, was 218/1470 (14.8%) and 252/585 (43.1%) for moderate mismatch and 43/198 (21.7%) and 61/105 (58.1%) for severe mismatch (p=0.02 and p=0.006). Multivariable predictors of late mortality were as follows: age ≥70 years, left ventricular ejection fraction ≤40%, indexed left ventricular mass >220g/m2 and concomitant coronary artery revascularization. After propensity score matching, conditional logistic regression analysis demonstrated no relationship between severe mismatch and increased mortality at 5 postoperative years (HR, 0.9; 95% CI, 0.7-1.6; p=0.06), whereas it was significant at 10 postoperative years (HR, 1.9; 95% CI, 1.2-2.5; p=0.03). During the follow-up, severe mismatch was associated with more frequent hospital readmissions for cardiac events (0.12 vs. 0.08 events/patient/year, p=0.007).
CONCLUSIONS: Patients with severe mismatch had lower long-term survival and higher incidence of hospital readmissions for cardiac events. However, the effect of severe mismatch on outcome appeared mainly related to the preoperative risk profile of each patient.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Aortic valve replacement; Moderate prosthesis-patient mismatch; Severe prosthesis-patient mismatch

Mesh:

Year:  2016        PMID: 27492659     DOI: 10.1016/j.jjcc.2016.07.003

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  6 in total

1.  A mechanistic investigation of the EDWARDS INTUITY Elite valve's hemodynamic performance.

Authors:  Vahid Sadri; Charles H Bloodworth; Immanuel David Madukauwa-David; Prem A Midha; Vrishank Raghav; Ajit P Yoganathan
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-06-27

2.  Sutureless valve and rapid deployment valves: a systematic review and meta-analysis of comparative studies.

Authors:  Campbell D Flynn; Michael L Williams; Adam Chakos; Lucy Hirst; Benjamin Muston; David H Tian
Journal:  Ann Cardiothorac Surg       Date:  2020-09

3.  The effect of patient-prosthesis mismatch on survival after aortic and mitral valve replacement: a 10 year, single institution experience.

Authors:  Sudeep Das De; Ashok Nanjappa; Karim Morcos; Sadia Aftab; John Butler; Vivek Pathi; Philip Curry; Sukumaran Nair
Journal:  J Cardiothorac Surg       Date:  2019-12-06       Impact factor: 1.637

4.  Patient Prosthesis Mismatch After SAVR and TAVR.

Authors:  Sabine Bleiziffer; Tanja K Rudolph
Journal:  Front Cardiovasc Med       Date:  2022-03-30

5.  Determinants of Aortic Prosthesis Mismatch in a Brazilian Public Health System Hospital: Big Patients or Small Prosthesis?

Authors:  Maria Estefania Otto; Fernando Antibas Atik; Marcelo do Nascimento Moreira; Luiz Carlos Madruga Ribeiro; Bianca Corrêa Rocha de Mello; Joyce Gomes Elias Lima; Maiara Sanchez Ribeiro; Ana Carolina Pereira Matos Domingues; Reyna Pinheiro Calzada; Armindo Jreige; Larissa Lucas Schloicka; Philippe Pibarot
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

6.  Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial.

Authors:  C S Hiremath; Anil R Jain; Anurag Garg; Nirmal Gupta; Yugal K Mishra; Zile Singh Meharwal; Nityanand Thakur; Atul A Maslekar; Naman Shastri
Journal:  J Cardiothorac Surg       Date:  2020-06-15       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.